Fujifilm Holdings Corp said on Tuesday that it expects its influenza drug Avigan to become a highly effective drug to treat Ebola.
Fujifilm Holdings Corp
Breaking News
- TikTok Voluntarily Suspends New App's Task and Reward Program After EU Regulators Express Concern Over Addictive Effects Among Young Users
- FairPrice Group Launches Mega $4.5 Million Savings Event for May Day: Exclusive Discounts, Deals, and More
- Austrian Modernist Gustav Klimt's 'Lost' Portrait Sells for €30M in Vienna Auction
Japan's Fujifilm Holdings Corp said on Monday it would buy 49 percent of Texas-based Kalon Biotherapeutics LLC, which has expertise in manufacturing vaccines used against pandemic influenza, Ebola and other public-health threats.
Japan's Fujifilm Holdings Corp said on Monday it was expanding the production of its Avigan anti-influenza drug to reach an additional number of Ebola patients.
Subscribe to VCpost newsletter
Most Popular
- Doctors Raise Concerns Over Proposed Capital Gains Tax Changes
- Where's My Child Tax Credit 2024: When to Receive My Money After April 15 Tax Filing Deadline?
- Celebrity Designer Nancy Gonzalez Jailed for Smuggling Crocodile, Python Handbags
- IBM Set to Acquire HashiCorp in Possible Mega-Deal, Stock Skyrockets 24% to $6.1 Billion Valuation
- Kroger and Albertsons to Sell off 166 Stores in Effort to Gain Approval for Their $25 Billion Merger
- How to Get IRS Unclaimed Tax Refunds: Here's What to Do If You Think You Have Pending Payments
- Student Loan Forgiveness Processing for This Group of Borrowers Will Stop Next Week
- Stellantis Plans to Lay Off Unspecified Number of Workers at US Factories in Coming Months
